ACAD — Acadia Pharmaceuticals Inc
Acadia Pharmaceuticals Inc (ACAD) is listed on NASDAQ.
It operates in the HEALTHCARE sector (BIOTECHNOLOGY).
If you are here to check Acadia Pharmaceuticals Inc before deciding, you get an interactive chart, momentum and risk scores, current headlines and alerts you can set on ACAD.
The scores shown here come from a model trained on real market data across seven technical indicators; it estimates both the probability of a rise and the level of risk, and shows both openly.
What ACAD is
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company is headquartered in San Diego, California.…
Acadia Pharmaceuticals Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
ACAD size and valuation
At roughly $3.40B, ACAD is a mid-cap.
It earns 2.19 per share and trades at 9.0 times that, a multiple that implies the market expects little growth.
Beta is 0.89: historically it has moved roughly with the market.
ACAD over the past year
Over the past year ACAD has traded between $19.45 and $30.96, and the current price sits at 15% of that range.
Trading near the low end of a 52-week range is a different situation from a bad day: it means the year, not the session, has gone against it.
The 50-day average is $26.74 against a 200-day average of $24.33 — the shorter average sits above the longer one, the configuration usually read as an uptrend.
The published analyst target is $32.16, 51.5% above it. A target is an aggregate of opinions, not a measurement.
How Acadia Pharmaceuticals Inc (ACAD) is trading
Acadia Pharmaceuticals Inc (ACAD) trades at $21.23, close to unchanged in the latest session (-0.05%).
The session ranged from $20.59 to $21.44 — 4.0% of the share price — and the current price sits at 76% of that range.
The two readings disagree: against the previous close ACAD is red (-0.05%), but measured from the $21.00 open it is up 1.10%. The -1.1% opening gap is what separates them.
The session covered 4.0% of ground and ended almost where it started — a lot of movement without direction.
Volume ran near 1.8M shares, about $37.6M of stock changing hands.
Traded alongside ACAD
Names traded alongside ACAD in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).
What VAQO's model says about ACAD
Two statistical models run over ACAD inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
Instrument details
- Symbol: ACAD
- Name: Acadia Pharmaceuticals Inc
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
ACAD — frequently asked questions
What is the market cap of ACAD?
Acadia Pharmaceuticals Inc has a market capitalisation of roughly $3.40B.
What is the 52-week range for ACAD?
ACAD has traded between $19.45 and $30.96 over the past year, with the current price at 15% of that range.
What is the P/E ratio of ACAD?
ACAD trades at 9.0 times earnings, on earnings per share of 2.19.
How much does ACAD stock cost today?
Acadia Pharmaceuticals Inc (ACAD) trades at $21.23, a change of -0.05% in the latest session.
Is ACAD up or down today?
ACAD is down 0.05% in the latest session, at $21.23.
What is the daily trading range for ACAD?
ACAD traded between $20.59 and $21.44 in the latest session, and currently trades at $21.23.
What is the trading volume for ACAD?
ACAD traded roughly 1.8M shares in the latest session.
Which exchange is ACAD listed on?
ACAD is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ACAD stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ACAD figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
More HEALTHCARE stocks
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
Last updated: 2026-11-08